The first OS 4 Up systems are set to reach South African shores in early March, following their international launch last year by Oertli Instrumente AG. We are incredibly excited to welcome this next-generation surgical platform for cataract and vitreoretinal surgery to local theatres. 

Designed and manufactured in Switzerland, the OS 4 Up combines physics and fluidics to translate precision into tangible comfort in the operating room. A key innovation is Phaco Assisted Cataract Surgery (PACS), which detects resistance at the phaco tip and automatically adjusts energy delivery in real time — maintaining constant longitudinal tip movement regardless of lens density and supporting controlled, efficient performance under stable chamber conditions. 

The platform also introduces dynamic infusion, compensating for IOP fluctuations and allowing surgeons to work closer to physiological pressure levels while maintaining chamber stability — even at high flow and vacuum settings. 

“For us, the OS 4 Up is much more than a technological upgrade – it embodies the essence of what Oertli stands for,” says Thomas Bosshard, Co-CEO of Oertli Instrumente AG. “Surgeons and OR teams dedicate thousands of hours in the operating theatre preserving eyesight. With the OS 4 Up, complemented by our innovative instruments, we enable them to enjoy their surgery – working with confidence, efficiency and joy, while delivering the best outcomes for patients.” 

We look forward to supporting South African surgeons as they begin operating with the OS 4 Up — a platform defined by precision, stability and joy in surgery.

 

               

 

Introducing the Oertli OS 4 UP – Enjoy Surgery


Introducing the Oertli OS 4 UP – Enjoy Surgery


The 12th Thessaloniki International Vitreo-Retinal Summer School (TVRS)

Thessaloniki, Greece – The 12th TVRS recently concluded with great success, leaving lasting impressions on all participants. A diverse group of participants, ranging from novices to experienced VR surgeons, attended the course.

The summer school boasted an impressive line-up of 53 subject matter experts (coaches), who catered to the needs of the 48 participants. The course format offered a combination of high-level didactic sessions along with hands-on coaching in a wet lab environment. Participants were able to engage, one-on-one with the coaches in an informal setting, fostering an understanding for each individual participant.

 

Thessaloniki, Greece - Learning

 

Covering a broad spectrum of topics, the TVRS explored the posterior segment of the eye with reference to relevant anterior matters. Ground-breaking technologies were showcased, providing valuable insights into the future of retinal surgery. The event featured close to 30 wet lab stations along with a state-of-the-art VR Magic retinal surgical simulator.

A highlight of the programme was the scoring of participants’ proficiency using the VR simulator, along with a comprehensive final exam covering all subjects presented during the week. Eighteen participants represented South Africa. In addition, two South African members, Dr. Marissa Willemse and Dr. Bernard Wolff, served on the Scientific faculty and eloquently delivered insightful presentations in their respective areas of expertise.

 

Thessaloniki, Greece - Training

 

After long and rewarding days, participants were treated to the renowned Greek hospitality, reinforcing Thessaloniki’s reputation as the food capital of Greece. The event concluded with a sense of accomplishment and a desire to build on the knowledge gained in the field of Vitreo-Retinal surgery.

 

Thessaloniki, Greece - Experience

 

The larger-than-life TVRS director, Prof. Athanasios Nikolakopoulos succeeded in delivering a world-class learning experience, as well as making each and everyone feel as if they were part of the TVRS “family”.

The Envision Africa team, consisting of Amy Prinsloo and our CEO James Wright were extremely proud to be part of this event and enjoyed showcasing the Oertli OS 4. Three advanced Oertli OS 4’s were made available to participants in the wet lab. This was an exceptional experience for Envision Africa and we cannot wait for the next TVRS.

 

After several years of effort, we at Envision are proud to announce our ISO 13485 certification. As both manufacturer and distributor, the requirements placed on us by the standard are very demanding. DQS, our conformity assessment body of choice, conducted the certification audit on the 26th of February and has now certified us with no findings to report. DQS is an internationally recognised certification body and so has very stringent standards.

We will continue to strive for excellence in quality management.

Certificate

ADDRESS TO ENVISION CUSTOMERS

Dear valued customer,

In light of the COVID-19 pandemic and subsequent lockdown, Envision has taken measures in line with Government guidelines and requirements to maintain continuity of service and supply in case of emergency.

We have surveyed the needs of all our customers and based on the response we have scaled back our operations to only the absolute essentials. Our production will continue in a strictly limited fashion and our logistics will operate on a purely as-and-when needed basis. We have elected to make sole use of couriers to limit the number of staff who need to travel. As a result of this and the fact that couriers have reduced their respective operations, a minimum lead time of 48 hours for emergency deliveries will apply.

Our ophthalmic representatives and technicians will remain on standby to attend theatre in case of emergency only. Please ensure that you have a well justified reason to request their presence in theatre and please be available should the authorities need to confirm the essentiality of their attendance.

For further information on the COVID-19 pandemic, please visit the Government website located at: https://sacoronavirus.co.za/

We wish you and your family health and safety during this time would like to reassure you that we stand ready to recommence full operation at the closure of the lockdown.

Yours faithfully,

James Wright

CEO